scorecardresearch
Wednesday, October 30, 2024
TopicPharmaceutical companies

Topic: Pharmaceutical companies

24 mega-seller drugs set to lose patents in US, big opportunity for Indian drugmakers — govt report

Patent expiry would mean that drugmakers will be able to launch generic versions of the blockbuster drugs, which are typically priced up to 90 percent lower than their innovator drug.

Import alerts, warning letters, drug recalls — why ‘pharmacy to the world’ is facing US FDA heat

New Delhi: On 18 April, Mumbai-headquartered Marksans Pharma, a drugmaker that supplies generic drugs in over 50 countries around the world, received form 483,...

Indian pharma market can more than treble by 2030, says industry report, urges focus on quality

Report by Organisation of Pharmaceutical Producers of India and Ernst & Young says growth could be propelled by expansion in the domestic market, spurred by India's economic growth.

2 cough syrups found ‘contaminated’, regulator launches probe into Gujarat drugmaker

CDSCO says two cough syrups manufactured by Ankleshwar-based Norris Pharma were found to contain Ethylene Glycol (EG) & Diethylene Glycol (DEG) beyond acceptable limits.

Patients’ groups oppose changes to patent rules, say could hinder access to affordable medicines

The groups say Draft Patents (Amendment) Rules could make it harder to challenge patent applications, impede process of obtaining compulsory licences & effect transparency in system.

After small firms, India’s drug regulator puts big companies supplying to US, EU under scanner

Exercise by Central Drugs Standard Control Organisation began as crackdown on small & medium drugmakers, but is being expanded to include major firms after complaints over quality control.

Indore firm linked to cough syrup deaths in Cameroon told to halt manufacture, govt tells Parliament

Naturcold, cough syrup supplied by Riemann Labs, was linked to deaths of 12 kids in Cameroon in March. This is 1st admission by govt of action taken in matter which was flagged by WHO.

Regulatory actions taken against 105 pharma companies, says health minister Mansukh Mandaviya

The action by national and state regulators comes after Indian-made cough syrups were linked to the deaths of dozens of children overseas.

WHO says 20 ‘contaminated’ drugs from Indian & Indonesian makers under scanner

WHO spokesperson says instances of contaminated drugs being found in 6 countries warranted Medical Product Alerts & that it takes reports of substandard medical products seriously.

Glenmark slashes price of HER2-positive breast cancer drug Trumab by 70%, making it cheapest in India

Breast cancer is one of the most commonly diagnosed cancers in India. Most existing Trastuzumab brands in Indian market are priced between Rs 40,000 and Rs 54,000 per 440 mg vial.

On Camera

Hyderabad has a HYDRAA-headed bulldozer story. Saving lakes or razing opposition?

Revanth Reddy’s bulldozing of lake ‘encroachments’ with new agency HYDRAA have left some serious questions unanswered, especially regarding the selective nature of the work undertaken.

iPhone craze, Goa trips, to making ends meet, ‘addictive’ instant loan apps leading many into debt trap

Unsecured loans have been a concern for RBI for a while now. Last year, it took steps to make it more expensive for banks, NBFCs to give them out in bid to deter such borrowing.

India-China disengagement completed at Depsang & Demchok, patrolling to start after Diwali

Corps commanders signed an agreement on 21 October to pull back troops from eastern Ladakh’s two face-off points, following efforts on diplomatic front to ease tensions along LAC.

From 2004 to 2024, bad news has come wrapped as good news for Congress

Congress is silently acknowledging it over-read verdict of last general election. You can see it in easy concession to SP. It will likely be more reasonable in Maharashtra & Jharkhand.